CureDiab at the EASD Annual Meeting 2022

31. August 2022

From 19th-23rd of September we will join the Annual Meeting of the European Association for the Study of Diabetes (EASD) to support rapid diffusion of acquired knowledge in the field of diabetes/NAFLD. Thus, we will present our discovery about the hepatoprotective activity of positive allosteric modulators of the GABAA receptor including extended findings. We are looking forward to join interesting talks and discuss about the latest updates on drug development for NAFLD. Do not hesitate to contact us and meet us there.